Merck KGaA
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
公司地址 Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
電話號碼 +49 6151720
傳真號碼 +49 6151722000
公司網頁 https://www.merckgroup.com
員工數量 62461
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
沒有相關資料。
 
董事會成員
董事會 職務 更新日期
Dr. Carla Kriwet, PhD Member of the Supervisory Board 18/02/2026
Ms. Barbara Lambert Member of the Supervisory Board 18/02/2026
Ms. Katja Garcia Vila Member of the Supervisory Board 18/02/2026
Mr. Stefan Palzer Member of the Supervisory Board 18/02/2026
Mr. Michael Reinhart Member of the Supervisory Board 18/02/2026
Ms. Sandra Schwebke Member of the Supervisory Board 18/02/2026
Mr. Michael Kleinemeier Chairman of the Supervisory Board 18/02/2026
Mr. Sven Vollrath Member of the Supervisory Board 18/02/2026
Dr. Susanne Schaffert, PhD Member of the Supervisory Board 18/02/2026
Ms. Birgit Biermann Member of the Supervisory Board 18/02/2026
Ms. Anne Lange Vice Chairman of the Supervisory Board 18/02/2026
Dr. Dietmar Oeter Member of the Supervisory Board 18/02/2026
Mr. Alexander Putz Member of the Supervisory Board 18/02/2026
Mr. Christian Raabe Member of the Supervisory Board 18/02/2026
Mr. Daniel Thelen Member of the Supervisory Board 18/02/2026
Mr. Simon Thelen Member of the Supervisory Board 18/02/2026
 
所屬ETF (更新日期: 02/05/2026 03:41)
代號 名稱 佔比% ▼ 持有日期
ENHIiShares Enhanced International Actv ETF0.00002%28/04/2026
PBDMInvesco PureBeta FTSE Dev ex-NrthAmr ETF0.00001%31/05/2023
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%06/03/2026
DDWMWisdomTree Dynamic International Eq ETF<0.000001%23/10/2025
DOLWisdomTree True Developed Intl ETF<0.000001%23/10/2025
DWMWisdomTree International Equity ETF<0.000001%23/10/2025
EEAEuropean Equity Fund<0.000001%31/12/2025
EFGiShares MSCI EAFE Growth ETF<0.000001%04/03/2026
EUDGWisdomTree Europe Quality Div Gr ETF<0.000001%23/10/2025
HAWXiShares Currency Hdgd MSCI ACWI exUS ETF<0.000001%06/03/2026
HEDJWisdomTree Europe Hedged Equity ETF<0.000001%23/10/2025
HEFAiShares Currency Hedged MSCI EAFE ETF<0.000001%03/03/2026
HEZUiShares Currency Hedged MSCI Eurozn ETF<0.000001%05/03/2026
INEQColumbia Intl Equ Income ETF<0.000001%28/11/2025
INTFiShares International Equity Factor ETF<0.000001%04/03/2026
IVSIApplied Finance IVS International LrgETF<0.000001%13/04/2026
JSTCAdasina Social Justice All Cp Glbl ETF<0.000001%28/11/2025
LCTDiShares Wld ex USCrbTrnstnRdnssAwrActETF<0.000001%06/03/2026
PQNTPictet AI Enhanced International Eq ETF<0.000001%22/01/2026
WRNDNYLI Global Equity R&D Leaders ETF<0.000001%28/08/2025
  1    2    3    4    5   6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.